Application of comparative effectiveness research in evaluation of treatments for type 2 diabetes mellitus.

Medicine & Life Sciences

• Comparative Effectiveness Research 100%
• Type 2 Diabetes Mellitus 49%
• Incretins 21%
• Patient Protection and Affordable Care Act 11%
• Therapeutics 10%
• Clinical Trials 10%
• Glucagon-Like Peptide-1 Receptor 10%
• Health Care Reform 10%
• Delivery of Health Care 10%
• Cost Savings 9%
• Administrative Personnel 8%
• Drug Development 7%
• Practice Guidelines 7%
• Health Care Costs 7%
• Cost-Benefit Analysis 7%
• Observational Studies 6%
• Meta-Analysis 6%
• Chronic Disease 6%
• Systematic Reviews 6%
• Public Health 5%
• Placebos 5%
• Pharmaceutical Preparations 3%

Social Sciences

• chronic illness 65%
• evaluation 30%
• Healthcare 19%
• Clinical Trials 17%
• drug 11%
• costs 9%
• Chronic Diseases 9%
• comparative research 9%
• savings 8%
• clinician 7%
• utilization 6%
• best practice 6%
• public health 6%
• act 5%
• innovation 5%
• reform 4%
• economics 3%